Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2016 May:98:86-91.
doi: 10.1016/j.tube.2016.02.007. Epub 2016 Mar 3.

Elevated serum 25-hydroxy (OH) vitamin D levels are associated with risk of TB progression in Gambian adults

Olumuyiwa Owolabi  1 , Schadrac Agbla  2 , Patrick Owiafe  3 , Simon Donkor  2 , Toyin Togun  2 , Abdou K Sillah  2 , Martin O C Ota  4 , Jayne S Sutherland  2
Affiliations
Comparative Study

Elevated serum 25-hydroxy (OH) vitamin D levels are associated with risk of TB progression in Gambian adults

Olumuyiwa Owolabi et al. Tuberculosis (Edinb). 2016 May.

Abstract

Background: Vitamin D is essential in the host defence against tuberculosis (TB) as an immune modulator. The aim of this study was to determine the level of 25-hydroxyvitamin D (25 (OH) D) from adult TB index cases before and after treatment and their exposed household contacts (HHC) in The Gambia.

Methods: Serum from adult index TB cases and their TB-exposed household contacts (HHC) was analysed for 25(OH) D and Vitamin D binding protein (VDBP) concentrations. Tuberculin skin test (TST) status was used as a measure of Mycobacterium tuberculosis (Mtb) infectivity in the HHC. In addition, HHC who later progressed to active TB (incident cases) were assessed alongside non-progressors to determine the influence of 25 (OH) D levels on TB risk.

Results: Eighty-three TB cases, 46 TST+ and 52 TST- HHC were analysed. Generally levels of 25(OH) D were considered insufficient in all subjects. However, median levels of 25(OH) D and VDBP were significantly higher in TB cases compared to both TST+ and TST- HHC at recruitment and were significantly reduced after TB therapy (p < 0.0001 for all). In addition, levels of serum 25(OH) D at recruitment were significantly higher in TB progressors compared to non-progressors (median (IQR): 25.0(20.8-29.2) in progressors and 20.3 (16.3-24.6) ng/ml in non-progressors; p = 0.007).

Conclusion: In The Gambia, an equatorial country, 25(OH) D levels are higher in serum of TB progressors and those with active disease compared to latently infected and uninfected subjects. These results contrast to findings in non-equatorial countries.

Keywords: 25(OH) D; Incident cases; Latent TB infection; Tuberculosis; Vitamin D binding protein.

PubMed Disclaimer

Figures

Figure 1
Figure 1
25(OH) D levels in TB cases and household contacts (HHC). A: Serum 25(OH) D levels were measured using ELISA. Box plots (5–95%) are shown for Serum 25(OH) D levels of TB cases at recruitment (R) and 6 months of treatment and TST+ and TST− HHC at recruitment. Line indicates median and dots indicate outliers. B: Serum Vitamin D Binding Protein levels were measured using ELISA. Box plots (5–95%) are shown for TB cases pre and post-treatment compared to TST+ and TST− HHC. Data were analysed using Random effects modelling and Wilcoxon Ranked Sums test (for comparison of TB cases at recruitment and 6 months). A p-value ≤ 0.05 was considered significant.
Figure 2
Figure 2
Median 25(OH) D levels of TB cases and Household contacts (HHC) at recruitment. Median 25(OH) D levels at each month of recruitment for all participants are shown to reflect changes in levels of 25(OH) D levels.
See this image and copyright information in PMC

References

    1. Malik Z.A., Thompson C.R., Hashimi S., Porter B., Iyer S.S., Kusner D.J. Cutting edge: Mycobacterium tuberculosis blocks Ca2+ signaling and phagosome maturation in human macrophages via specific inhibition of sphingosine kinase. J Immunol. 2003;170:2811–2815. - PubMed
    1. Global tuberculosis control: key findings from the December 2009 WHO report. Wkly Epidemiol Rec. 2010;85:69–80. - PubMed
    1. Zumla A., George A., Sharma V. The WHO 2014 global tuberculosis report – further to go. Lancet Glob Health. 2015;3:e10–e12. - PubMed
    1. Ottenhoff T.H., Kaufmann S.H. Vaccines against tuberculosis: where are we and where do we need to go? PLoS Pathog. 2012;8:e1002607. - PMC - PubMed
    1. Hood M.L. A narrative review of recent progress in understanding the relationship between tuberculosis and protein energy malnutrition. Eur J Clin Nutr. 2013;67:1122–1128. - PubMed

Publication types

MeSH terms